Kogenta Nakamura

发表

Neoadjuvant therapy before radical prostatectomy: where have we been? Where are we going?

S. Anai, C. Rosser, L. Pisters, 2007, Urologic oncology.

Review article Neoadjuvant therapy before radical prostatectomy: Where have we been? Where are we going?

S. Anai, C. Rosser, L. Pisters, 2007 .

A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system.

S. Saga, R. Ueda, H. Akaza, 2011, Oncology Report.

The use of zoledronic acid in Japanese men with stage D2 prostate cancer.

C. Rosser, Kogenta Nakamura, S. Aoki, 2010, Oncology letters.

The use of enoxaparin to prevent venous thromboembolism in patients undergoing radical retropubic prostatectomy: feasibility and utility.

S. Anai, C. Rosser, John Pendleton, 2007, International braz j urol : official journal of the Brazilian Society of Urology.

Holmium YAG laser ablation of a hemangioma involving a lower pole renal calyx - using the new-generation flexible ureteroscope URF type P5®: a case report

C. Rosser, Kogenta Nakamura, S. Aoki, 2009, Cases journal.

Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium

Kogenta Nakamura, K. Zennami, S. Aoki, 2009, Cancer Chemotherapy and Pharmacology.

Optimal method for measuring tumor extent in needle biopsy specimens to identify small‐volume prostate cancer

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2016, International journal of urology : official journal of the Japanese Urological Association.

Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data.

M. Nishimura, Kogenta Nakamura, K. Zennami, 2010, Experimental and therapeutic medicine.

Is neuroendocrine cell differentiation detected using chromogranin A from patients with bone metastatic prostate cancer a prognostic factor for outcome?

Kogenta Nakamura, K. Zennami, S. Aoki, 2006, Oncology reports.

Impact of a novel biopsy instrument with a 25‐mm side‐notch needle on the detection of prostate cancer in transrectal biopsy

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2018, International journal of urology : official journal of the Japanese Urological Association.

Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report

C. Rosser, Kogenta Nakamura, N. Honda, 2010, BMC urology.

Cyclooxygenase-2 expression in invasive transitional cell carcinoma of the urinary bladder.

I. Kyoku, Kogenta Nakamura, K. Zennami, 2008, Molecular medicine reports.

Lactate dehydrogenase is a prognostic indicator for prostate cancer patients with bone metastasis.

Kogenta Nakamura, K. Zennami, S. Aoki, 2007, Hinyokika kiyo. Acta urologica Japonica.

Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology.

S. Saga, H. Akaza, Kogenta Nakamura, 2006, International journal of oncology.

Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder.

Kogenta Nakamura, K. Zennami, S. Aoki, 2010, Oncology reports.

Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.

Kogenta Nakamura, K. Zennami, S. Aoki, 2008, Oncology reports.

Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization.

Kogenta Nakamura, K. Zennami, S. Aoki, 2007, Oncology reports.

Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer.

Kogenta Nakamura, K. Zennami, S. Aoki, 2007, Oncology reports.

Enhancement of enterohemorrhagic Escherichia coli O157:H7 stress tolerance via pre-heating.

Kogenta Nakamura, M. Sumitomo, M. Nitta, 2011, Molecular medicine reports.

Prediction of in vitro response to interferon‐α in renal cell carcinoma cell lines

H. Akaza, T. Kojima, J. Miyazaki, 2007 .

Solitary brain metastasis from pT1, G3 bladder cancer

Kogenta Nakamura, K. Zennami, S. Aoki, 2008, International journal of urology : official journal of the Japanese Urological Association.

Prostatic Pharmacokinetic/Pharmacodynamic Evaluation of Ampicillin‐Sulbactam for Bacterial Prostatitis and Preoperative Prophylaxis

Kogenta Nakamura, K. Ikawa, N. Morikawa, 2020, Journal of clinical pharmacology.

Irradiation of human prostate cancer cells increases uptake of antisense oligodeoxynucleotide.

S. Goodison, S. Anai, C. Rosser, 2007, International journal of radiation oncology, biology, physics.

Management of adverse events in patients with metastatic renal cell carcinoma treated with sunitinib and clinical outcomes.

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2013, Anticancer research.

MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3

Kogenta Nakamura, Motohiko Sato, A. Yamamura, 2021, Frontiers in Pharmacology.

A rare case of metastatic renal carcinoid

Kogenta Nakamura, S. Aoki, N. Honda, 2010, BMC urology.

Clinical features of renal cell carcinoma less than 25 millimeters in diameter

Kogenta Nakamura, S. Aoki, N. Honda, 2002, International journal of urology : official journal of the Japanese Urological Association.

Treatment of upper urinary tract stones with extracorporeal shock wave lithotripsy (ESWL) Sonolith vision

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2011, BMC urology.

Ammonium acid urate urinary stone caused by a low-caloric diet: a case report.

Kogenta Nakamura, S. Aoki, N. Honda, 2002, Hinyokika kiyo. Acta urologica Japonica.

Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic–pharmacodynamic evaluation

Kogenta Nakamura, K. Zennami, K. Ikawa, 2012, Journal of chemotherapy.

Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients.

Kogenta Nakamura, K. Ikawa, N. Morikawa, 2010, International journal of antimicrobial agents.

Clinical pharmacokinetics and pharmacodynamic target attainment of pazufloxacin in prostate tissue: Dosing considerations for prostatitis.

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Clinical pharmacokinetics of flomoxef in prostate tissue and dosing considerations for prostatitis based on site-specific pharmacodynamic target attainment.

Kogenta Nakamura, K. Ikawa, N. Morikawa, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics.

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation.

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2013, International journal of antimicrobial agents.

The Prostate

T. Tsuzuki, R. Ueda, Kogenta Nakamura, 2019 .

An immunohistochemical study of chromogranin A and human epidermal growth factor‐2 expression using initial prostate biopsy specimens from patients with bone metastatic prostate cancer

Kogenta Nakamura, K. Zennami, S. Aoki, 2007, BJU international.

Prognostic significance of immunohistochemical expression of the HER-2/neu oncoprotein in bone metastatic prostate cancer.

S. Saga, K. Hara, Kogenta Nakamura, 2006, Urology.

Increased infiltration of CCR4‐positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis

T. Tsuzuki, R. Ueda, Kogenta Nakamura, 2019, The Prostate.

The therapeutic potential of a novel PSMA antibody and its IL-2 conjugate in prostate cancer.

K. Shitara, R. Ueda, M. Yamasaki, 2014, Anticancer research.

Endoscope‐assisted minilaparotomic radical retropubic prostatectomy

Kogenta Nakamura, S. Aoki, N. Honda, 2006, International journal of urology : official journal of the Japanese Urological Association.

Positive surgical margins at radical prostatectomy: importance of intra-operative bladder neck frozen sections.

S. Anai, C. Rosser, John Pendleton, 2007, International braz j urol : official journal of the Brazilian Society of Urology.

Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization.

S. Goodison, S. Anai, C. Rosser, 2007, Urology.

Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.

Kogenta Nakamura, S. Aoki, N. Honda, 2006, Oncology reports.

Axitinib-induced reversible posterior leukoencephalopathy syndrome in a patient with metastatic renal cell carcinoma

Kogenta Nakamura, M. Sumitomo, H. Muramatsu, 2017, International Cancer Conference Journal.

Long-term results and management of ureteral transitional cell carcinoma using the holmium: YAG laser via rigid-ureteroscopy.

I. Kyoku, Kogenta Nakamura, K. Zennami, 2009, Oncology reports.

Clinical experience of ureteroscopic treatment for ureteral transitional cell carcinoma using the Holmium:YAG laser.

Kogenta Nakamura, S. Aoki, N. Honda, 2003, Oncology reports.

Primary adenocarcinoma of the ureter: report of a case.

Kogenta Nakamura, K. Zennami, S. Aoki, 2007, Hinyokika kiyo. Acta urologica Japonica.

Imatinib mesylate inhibits androgen-independent PC-3 cell viability, proliferation, migration, and tumor growth by targeting platelet-derived growth factor receptor-α.

Kogenta Nakamura, Motohiko Sato, A. Yamamura, 2021, Life sciences.

Targeting lactate dehydrogenase‑A promotes docetaxel‑induced cytotoxicity predominantly in castration‑resistant prostate cancer cells.

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2019, Oncology reports.

Targeting lactate dehydrogenase-A promotes docetaxel induced cytotoxicity predominantly in castration-resistant prostate cancer cells

Masami Watanabe, Kogenta Nakamura, M. Sumitomo, 2018 .

Prostate cancer knowledge and screening attitudes of inner-city men

S. Anai, C. Rosser, John Pendleton, 2008, Journal of Cancer Education.

Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria

K. Iczkowski, S. Anai, C. Rosser, 2009, BMC urology.

Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect.

Kogenta Nakamura, K. Zennami, S. Aoki, 2011, Experimental and therapeutic medicine.

Comparative investigation on clinical outcomes of robot‐assisted radical prostatectomy between experienced open prostatic surgeons and novice open surgeons in a laparoscopically naïve center with a limited caseload

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2015, International journal of urology : official journal of the Japanese Urological Association.

Knowledge and attitudes of primary care physicians regarding prostate cancer screening.

C. Rosser, John Pendleton, Kogenta Nakamura, 2007, Journal of the National Medical Association.

Successful Management of Pulmonary Tumor Embolism from Renal Cell Carcinoma

Kogenta Nakamura, K. Matsuyama, I. Sugimoto, 2018 .

Lactate dehydrogenase, Gleason score and HER-2 overexpression are significant prognostic factors for M1b prostate cancer.

Kogenta Nakamura, K. Zennami, S. Aoki, 2011, Oncology reports.

Inflammatory pseudotumors of the kidney and the lung presenting as immunoglobulin G4-related disease: a case report

Kogenta Nakamura, K. Zennami, S. Aoki, 2011, Journal of medical case reports.

205 Transactivation of the EGFR cell survival pathway under hypoxia mediates mTOR activation and induction of HIF-α proteins and resistance to rapamycin especially in wild-type VHL renal cell carcinoma

Kogenta Nakamura, M. Sumitomo, S. Aoki, 2012 .

Vesicourethral Anastomotic Suture Placement during Radical Prostatectomy Using Maniceps

Kogenta Nakamura, S. Aoki, N. Honda, 2003, Urologia Internationalis.

Significant prognostic factor of immunohistochemical HER‐2 expression using initial prostate biopsy specimens with M1b prostate cancer

T. Yokoi, Kogenta Nakamura, K. Zennami, 2011, The Prostate.

Dorsal Vein Complex Preserving Technique During Robot-Assisted Radical Prostatectomy.

Kogenta Nakamura, H. Muramatsu, I. Kobayashi, 2020, Journal of endourology case reports.

The Feasibility of Expectant Management with Inner-city Men with Newly Diagnosed Localized Prostate Cancer

S. Anai, C. Rosser, John Pendleton, 2008, Journal of health care for the poor and underserved.

[A case of self-mutilation of testis].

Kogenta Nakamura, N. Honda, Yoshiaki Yamada, 2002, Hinyokika kiyo. Acta urologica Japonica.

Comparing Six-and Twelve-Core Prostate Biopsy in Detection of Prostate Cancer

Kogenta Nakamura, N. Honda, M. Tobiume, 2008 .

Retrospective study comparing six- and twelve-core prostate biopsy in detection of prostate cancer.

Kogenta Nakamura, N. Honda, M. Tobiume, 2008, International braz j urol : official journal of the Brazilian Society of Urology.

Effective Treatment of Bladder Tumor-Bearing Mice by Direct Delivery of Bleomycin Using Electrochemotherapy

Kogenta Nakamura, K. Yoshikawa, N. Honda, 2002, Drug delivery.

Further investigation of the epitope recognized by the new monoclonal antibody 2C9

K. Shitara, S. Saga, R. Ueda, 2003, International journal of urology : official journal of the Japanese Urological Association.

Abstract 3961: Increased CCR4-positive regulatory T cells in biopsy specimen of poor prognosis prostate cancer

R. Ueda, Kogenta Nakamura, M. Sumitomo, 2017 .

Increased CCR4-positive regulatory T cells in biopsy specimens of poor prognostic prostate cancer

R. Ueda, Masami Watanabe, Kogenta Nakamura, 2017 .